Wallack MK - Search Results

1

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM, Bartolucci AA, et al. Wallack MK, et al. Cancer. 1995 Jan 1;75(1):34-42. doi: 10.1002/1097-0142(19950101)75:1<34::aid-cncr2820750108>3.0.co;2-0. Cancer. 1995. PMID: 7804974 Clinical Trial.

2

Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.

Tanaka N, Sivanandham M, Wallack MK. Tanaka N, et al. Among authors: wallack mk. J Immunother Emphasis Tumor Immunol. 1994 Nov;16(4):283-93. doi: 10.1097/00002371-199411000-00006. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7881637

3

Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.

Sivanandham M, Scoggin SD, Tanaka N, Wallack MK. Sivanandham M, et al. Among authors: wallack mk. Cancer Immunol Immunother. 1994 Apr;38(4):259-64. doi: 10.1007/BF01533517. Cancer Immunol Immunother. 1994. PMID: 8168121 Free PMC article.

4

Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial.

Wallack MK, Sivanandham M, Whooley B, Ditaranto K, Bartolucci AA. Wallack MK, et al. Ann Surg Oncol. 1996 Mar;3(2):110-7. doi: 10.1007/BF02305788. Ann Surg Oncol. 1996. PMID: 8646509 Clinical Trial.

5

Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial.

Wallack MK, Sivanandham M, Ditaranto K, Shaw P, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Rosen L, Bartolucci AA. Wallack MK, et al. Ann Surg. 1997 Aug;226(2):198-206. doi: 10.1097/00000658-199708000-00012. Ann Surg. 1997. PMID: 9296514 Free PMC article. Clinical Trial.

6

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial.

Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Bartolucci AA, Rosen L. Wallack MK, et al. J Am Coll Surg. 1998 Jul;187(1):69-77; discussion 77-9. doi: 10.1016/s1072-7515(98)00097-0. J Am Coll Surg. 1998. PMID: 9660028 Clinical Trial.

7

Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials.

Kim EM, Sivanandham M, Stavropoulos CI, Bartolucci AA, Wallack MK. Kim EM, et al. Among authors: wallack mk. Surg Oncol. 2001 Jul-Aug;10(1-2):53-9. doi: 10.1016/s0960-7404(01)00020-2. Surg Oncol. 2001. PMID: 11719029

8

Active specific immunotherapy with vaccinia melanoma oncolysate.

Wallack MK, Scoggin SD, Sivanandham M. Wallack MK, et al. Mt Sinai J Med. 1992 May;59(3):227-33. Mt Sinai J Med. 1992. PMID: 1318507 Review.

9

A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates.

Wallack MK, McNally KR, Leftheriotis E, Seigler H, Balch C, Wanebo H, Bartolucci AA, Bash JA. Wallack MK, et al. Cancer. 1986 Feb 1;57(3):649-55. doi: 10.1002/1097-0142(19860201)57:3<649::aid-cncr2820570342>3.0.co;2-6. Cancer. 1986. PMID: 3943002

10

Experimental melanoma vaccines.

Sivanandham M, Kim EM, Wallack MK. Sivanandham M, et al. Among authors: wallack mk. IDrugs. 2002 Feb;5(2):159-70. IDrugs. 2002. PMID: 12861477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters